[Choice of the correction method and results of surgery in patients with mitral, aortic and tricuspid defects of the heart].

Grudnaia khirurgiia (Moscow, Russia) Pub Date : 1989-07-01
G I Tsukerman, V S Dubrovskiĭ, A I Malashenkov, N Shamshiev
{"title":"[Choice of the correction method and results of surgery in patients with mitral, aortic and tricuspid defects of the heart].","authors":"G I Tsukerman,&nbsp;V S Dubrovskiĭ,&nbsp;A I Malashenkov,&nbsp;N Shamshiev","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>The article analyses the results of surgical correction of tri-valvular heart diseases in 132 patients who were operated on between January, 1973 and March, 1986. Total hospital mortality was 20.4%. Among the last 72 operations conducted from January, 1980 hospital mortality amounted to 14.0% (10 patients died). The results of the operations were approximately the same in the different methods of correction: 105 patients were studied in late follow-up periods (from 6 months to 14 years). With consideration for the hospital losses, by the 7th year of follow-up the survival after prosthetic replacement of 3 valves was 61.8%, after replacement of the mitral and aortic and valvuloplasty of the tricuspid valve--60.6 degrees. The stability of good results was 59.6 and 58.1%, respectively. Among and analogous group of patients who received drug treatment survival by the 7th year was 28.1%, which is evidence of the obvious advantages of the surgical method of treatment. The results were best in patients subjected to plastic operations on two and three valves.</p>","PeriodicalId":73184,"journal":{"name":"Grudnaia khirurgiia (Moscow, Russia)","volume":" 4","pages":"21-5"},"PeriodicalIF":0.0000,"publicationDate":"1989-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Grudnaia khirurgiia (Moscow, Russia)","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

The article analyses the results of surgical correction of tri-valvular heart diseases in 132 patients who were operated on between January, 1973 and March, 1986. Total hospital mortality was 20.4%. Among the last 72 operations conducted from January, 1980 hospital mortality amounted to 14.0% (10 patients died). The results of the operations were approximately the same in the different methods of correction: 105 patients were studied in late follow-up periods (from 6 months to 14 years). With consideration for the hospital losses, by the 7th year of follow-up the survival after prosthetic replacement of 3 valves was 61.8%, after replacement of the mitral and aortic and valvuloplasty of the tricuspid valve--60.6 degrees. The stability of good results was 59.6 and 58.1%, respectively. Among and analogous group of patients who received drug treatment survival by the 7th year was 28.1%, which is evidence of the obvious advantages of the surgical method of treatment. The results were best in patients subjected to plastic operations on two and three valves.

[心脏二尖瓣、主动脉瓣和三尖瓣缺损患者手术矫正方法的选择及结果]。
本文分析了1973年1月至1986年3月间132例三瓣膜性心脏病的手术矫正效果。住院总死亡率为20.4%。1980年1月以来进行的最后72例手术中,住院死亡率为14.0%(10例死亡)。不同矫正方法的手术结果大致相同:105例患者在后期随访期间(6个月至14年)进行了研究。考虑到医院的损失,到随访第7年,人工瓣膜置换术后的生存率为61.8%,二尖瓣和主动脉置换术和三尖瓣成形术后的生存率为60.6度。良好结果的稳定性分别为59.6%和58.1%。与同类组相比,接受药物治疗的患者第7年生存率为28.1%,说明手术治疗方法优势明显。接受两瓣和三瓣整形手术的患者效果最好。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信